Health Law Checkup - FDA Draft Guidance Aims to Clarify Appropriate Character-Space-Limited Social Media Use by Drug and Device Firms (Part I of II)
by Sara J. Agne and Daniel S. Wittenberg
As technology continues to evolve, so do the ways in which patients and healthcare providers obtain information pertaining to medical products regulated by the Food and Drug Administration (FDA). Thomas Abrams, Director of the FDA’s Office of Prescription Drug Promotion in the Agency’s Center for Drug Evaluation and Research acknowledged in a recent FDA blog post that in addition to traditional sources of medical product information, patients and healthcare providers are also obtaining information through social media and other internet sources. In response to this growing trend, the FDA issued two draft guidance documents in June that seek to establish some ground rules for prescription-drug and medical-device manufacturers (firms) seeking to present information about products via social media.